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Non- fatal strangulation (NFS) is a global public health and human 
rights issue.1 Prevalence estimates of NFS in sexual assault (SA) range 
from 7.4% to 12%.2,3 Strangulation associated with SA poses a lethal-
ity risk, both at the time of assault and through risk for future stran-
gulation. If the assailant is an intimate partner, a heightened risk exists 
for future attempted and completed homicide.4
This study explores prevalence, trends, and characteristics of SA 
involving NFS using a retrospective descriptive analysis of Sexual 
Assault Nurse Examiner (SANE) cases at one academic hospital in the 
Midwestern United States from 2002 to 2017. Data were extracted 
from systematic statewide SANE data collection forms and SANE 
notes for females after menarche and males ≥13 years (considered 
adults through the hospital protocol). The institutional review board of 
the hospital approved the study procedures. Descriptive statistics and 
chi- square tests were computed in SPSS version 25 (IBM, Armonk, NY, 
USA); P<0.05 were considered significant.
Of 856 cases, 95.7% of survivors were female and 61.1% were 
white. The average age was 24.16 years. In total, 5.1% of cases 
involved NFS. All NFS survivors were female, with 11.3% of females 
experiencing NFS. NFS was more common when current/former 
partners (18.9%) or strangers were assailants (16.6%), compared to 
family members (11.1%) or friends/acquaintances (7.9%; χ2(4)=9.72, 
P=0.045). NFS occurred more often in cases involving weapons than 
in cases without weapons (30.0% vs. 9.1%; χ2(1)=15.50, P<0.001). 
Additionally, NFS occurred more frequently in cases with anal pene-
tration than cases without (22.7% versus 7.5%; χ2(1)=16.19, P<0.001). 
NFS appears to increase over time (Fig. 1). The mean number of NFS 
cases annually was 1.8 from 2002 to 2007 (range 0–3), 2.4 from 2008 
to 2012 (range 1–5), and 4.6 from 2013 to 2017 (range 3–6).
These results indicate that NFS is common in SA involving females. 
Our findings are consistent with research showing that survivors 
experiencing SA by current/former partners are at an increased risk 
of lethality,2,3 followed by SA perpetrated by strangers. Furthermore, 
many survivors face a heightened risk of lethality through the com-
bination of weapons and strangulation. It is possible that NFS is 
increasing, but more data are needed. This study was limited by the 
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small number of NFS cases and data from one hospital, which may 
not be representative of cases at other health centers. However, the 
strengths include the large sample size and systematic data collection. 
These results highlight the importance of screening for strangulation 
when survivors of SA present for care and the need to tailor interven-
tions based on lethality risk.
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Pelvic inflammatory disease (PID) is associated with an increased risk of 
subsequent reproductive sequelae and possibly an increased incidence 
of endometrial, serous ovarian, and colorectal cancer.1–3 Any association 
with cancer may have important public health implications. The present 
study examined the incidence of cancer among women with PID.
In this Danish population- based cohort study, we linked data from 
the National Patient Registry,4 the Civil Registration System, and the 
Cancer Registry. We identified females (≥15 years) with incident PID 
diagnosed during 1978–2013 (using International Classification of 
Diseases, 8th and 10th Revision),4 and followed them for subsequent 
records of cancer diagnosis, death, emigration, or until termination of 
study (November 30, 2013). Women previously diagnosed with cancer 
were excluded from the present study.
We computed standardized incidence ratios (SIRs) and 95% con-
fidence intervals (CIs) to compare the observed against the expected 
number of cancers, estimating SIRs <1 year and ≥1 year from PID diag-
nosis. Expected numbers were calculated on the basis of national can-
cer incidence rates, using age and calendar period (5- year intervals). 
According to Danish law, use of registry data for research purposes 
does not require informed consent.
Among 93 706 females with PID, 542 cancers were diagnosed 
<1 year after a PID diagnosis, and 8727 cancers >1 year following a 
PID diagnosis. The SIR of any cancer <1 year following a PID diagnosis 
was 2.9 (95% CI; 2.7–3.2), with markedly elevated SIRs for urogeni-
tal and colorectal cancer. While most cancers were diagnosed among 
women over the age of 35, the SIR of any cancer was elevated for all 
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TABLE  1 Standardized incidence ratiosa for selected cancersb among 93 706 women with pelvic inflammatory disease (Denmark, 
1978–2013).
<1 y from PID diagnosis ≥1 y from PID diagnosis
O E SIR (95% CI) O E SIR (95% CI)




— — — 57 32.2 1.8 (1.3–2.3)
Vaginal — — — 17 6.9 2.5 (1.4–4.0)
Cervical 88 14.2 6.2 (5.0–7.6) 338 339 1.0 (0.9–1.1)
Uterine/endometrial 100 5.0 20.1 (16.3–24.4) 227 259 0.9 (0.8–1.0)
Ovarian 51 6.7 7.6 (5.6–9.9) 289 256 1.1 (1.0–1.3)
Kidney 7 1.6 4.3 (1.7–8.9) 98 71.9 1.4 (1.1–1.7)
Bladder 13 2.6 5.0 (2.6–8.5) 132 115 1.1 (1.0–1.4)
Other cancers
Colorectal 89 11.7 7.6 (6.1–9.4) 469 490 1.0 (0.9–1.1)
Breast 61 44.7 1.4 (1.0–1.8) 2214 2239 1.0 (1.0–1.0)
Lung 16 9.8 1.6 (0.9–2.7) 809 574 1.4 (1.3–1.5)
Malignant melanoma 12 13.5 0.9 (0.5–1.6) 468 454 1.0 (0.9–1.1)
Non- melanoma skin 
cancer
23 34.1 0.7 (0.4–1.0) 1920 1913 1.0 (1.0–1.1)
Non- Hodgkin  
malignant lymphoma
7 4.7 1.5 (0.6–3.1) 222 198 1.1 (1.0–1.3)
Brain 12 7.3 1.6 (0.9–2.9) 240 228 1.1 (0.9–1.2)
Metastases and  
non- specified cancer 
in lymph nodes
8 2.3 3.5 (1.5–7.0) 90 83 1.1 (0.9–1.3)
Sub- groups of cancer
Urinary 20 4.6 4.3 (2.7–6.7) 251 200 1.3 (1.1–1.4)
Gastrointestinal 101 18.9 5.4 (4.4–6.5) 813 794 1.0 (1.0–1.1)
Hematological 19 10.3 1.8 (1.1–2.9) 371 342 1.1 (1.0–1.2)
Smoking- related 41 19.4 2.1 (1.5–2.9) 1352 1026 1.3 (1.3–1.4)
Alcohol- related 157 62.5 2.5 (2.1–2.9) 3034 3022 1.0 (1.0–1.0)
Immune- related 123 61.8 2.0 (1.7–2.4) 2726 2707 1.0 (1.0–1.1)
Hormone- related 212 56.4 3.8 (3.3–4.3) 2730 2754 1.0 (1.0–1.0)
Age at PID diagnosis, years
15–19 5 2.6 1.9 (0.6–4.5) 627 560 1.1 (1.0–1.2)
20–24 13 6.8 1.9 (1.0–3.3) 1179 1100 1.1 (1.0–1.1)
25–29 30 12.0 2.5 (1.7–3.6) 1339 1275 1.1 (1.0–1.1)
30–34 36 18.1 2.0 (1.4–2.8) 1437 1351 1.1 (1.0–1.1)
35+ 458 146 3.1 (2.9–3.4) 4145 3927 1.1 (1.0–1.1)
Abbreviations: E, expected; O, observed; PID, pelvic inflammatory disease; SIR, standardized incidence ratio.
The age distribution of the cohort: 15–19 years: n=13 394 (14%); 20–24 years: n=19 514 (21%); 25–29 years: n=17 245 (18%); 30–34 years: n=14 697 
(16%); 35+ years: n=28 856 (31%).
aIndirect standardized incidence ratios (SIRs) were used as a measure of relative risk by comparing the cancer incidence observed among women with PID 
with the expected incidence in the general Danish female population. The observed number of a specific cancer subtype was compared with the expected 
number of that specific subtype.
bIn agreement with Danish data security regulations, the study only presents results for cancer sites with five or more cases.
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age groups >20 years. Beyond 1 year of follow- up, there was no asso-
ciation with cancer in general; however, individual cancers including 
kidney, lung, vaginal, and external female genitalia cancer remained 
higher than expected (Table 1).
The present study found a higher occurrence of several cancers 
within the first year after PID diagnosis, possibly explained by prev-
alent cancers detected during work- up for PID. The data suggested 
that some urogenital cancers may be overlooked at the time of 
PID diagnosis.
The strengths of the present study include the large sample 
size and virtually complete follow- up. The population- based reg-
istries are complete and have high data validity.4 Nevertheless, 
non- differential misclassification of patients could have resulted in 
biases toward the null. Moreover, individuals with subclinical PID, 
or a severity not requiring hospitalization, were not included in our 
cohort. Thus, the results may only apply to patients diagnosed with 
PID during hospital contact.
We disaggregated follow- up into <1 and ≥1 year to discern prev-
alent versus incident cases of cancer. Therefore, the findings of the 
present study do not suggest causality between PID and cancer. 
However, undetected urogenital and colorectal cancer may mimic or 
cause PID, and may be considered as a differential diagnosis of PID in 
women older than 35 years diagnosed during hospital contact.
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In Kenya, rural communities bear the greatest burden of maternal 
deaths. In West Pokot, there is an average of 7.2 children per mother 
compared to 2.7 in Nairobi, with a contraception prevalence of 14% 
versus 63% in the capital.1 Access, cost and cultural beliefs are barri-
ers to long- acting reversible contraceptive (LARC) uptake.2 The state 
of women's health in West Pokot presents a unique opportunity to 
reduce maternal mortality through family planning. The purpose 
of this ongoing prospective cohort study is to encourage childbirth 
spacing and develop trust in the uptake of LARCs in a low- resource, 
high- risk setting. IRB ethical approval was obtained in 2015 from the 
ahmEd and Shirazian
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Kenyan government through the Kenyatta National Hospital and the 
University of Nairobi.
All obstetric patients entering Kapenguria Hospital or other sat-
ellite clinics for prenatal care prior to 22 weeks of gestation were 
offered enrollment in the maternal continuum of care program (MCCP) 
(Fig. 1). The MCCP consists of three distinct prenatal visits. Consent 
was coordinated in Pokot or Swahilli by a local program coordinator 
and patients officially enrolled by signature or thumbprint at their first 
prenatal visit with ultrasound scan. After a second visit for preterm 
birth indicators, free LARCs were offered and the option of postpar-
tum placement was discussed. Surveys about LARCs were adminis-
tered prior to insertion, either following the delivery at the hospital 
or postpartum. Acceptability surveys were administered more than 
14 months post- placement.3
A total of 260 pregnant women consented to enrollment in 
the MCCP. All patients were offered contraceptive counseling and 
139 accepted LARC placement; 59 (42%) opted for levonorgestrel 
IUD and 55 (40%) chose the etonogestrel implant. Mean age was 
29.8 years and mean parity was 3 (range: 0–10). Seventy- nine 
(57%) cited localized hormonal effects and 26 (19%) reported 
reduced menses as factors in selecting the hormonal IUD. Among 
the 55 with etonogestrel implant, 21 (38%) cited ease of inser-
tion and 10 (18%) cited accessibility to arm implant. The majority 
of copper IUD users (15, 60%) desired to avoid hormonal treat-
ment. Thirty women completed the acceptability survey (Table 1). 
Twenty- two (73%) women confirmed that they were very likely to 
opt for an IUD again.
This global strategy of providing full- spectrum LARCs at no cost 
alongside tailored health education as the final step in the MCCP 
model was met with interest and initial satisfaction; it also helped to 
ensure that patients engaged with the local healthcare facilities, and 
to prevent pregnancy- related complications. Identification of further 
barriers to LARC uptake and longer- term follow- up to measure sat-
isfaction with these methods will be useful in improving access to 
high- quality contraception.
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F IGURE  1 Saving Mothers’ Maternal Continuum of Care Program.




26- 30 8 27%
31- 35 6 20%
>35 13 43%
Method chosen
Copper IUD 16 53%
LNG IUD 14 47%







Likelihood to recommend LARC
Very likely 23 77%
Somewhat likely 7 23%
Not likely 0 0%
Would recommend against 0 0%
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Postpartum hemorrhage (PPH) is the most frequent severe birth com-
plication and a significant cause of morbidity and preventable maternal 
deaths.1 The present study describes a new strategy for the preserva-
tion of the uterus, with a series of cases of PPH. Uterine devascular-
ization associated with compressive uterine suture (UD- CUS) consists 
of vascular ligature in the ascendant branches of the uterine arteries 
(one in the right and one in the left side of the organ), as recommended 
by O'Leary, and two vertical braces of compressive uterine suture, as 
recommended by Hayman.2,3 In the Hayman technique, two separated 
compressive sutures are made: one in the right and one in the left 
half of the uterus exteriorized from the abdominal cavity. The needle 
passes through the uterus only once (from front to back or vice versa) 
in a sagittal plane for each suture at the inner top level of the cer-
vix. Following on from this, each strap is then tied to the bottom of 
the uterus. The Hayman technique is useful for controlling bleeding in 
the uterine body (S1 genital vascular territory) and preventing uterine 
atony and placental accretism restricted to the uterus (Fig. 1).
Between January 2014 and May 2017, the UD- CUS technique was 
performed on 41 patients who presented with PPH but did not recover 
with pharmacological treatment. The Sofia Feldman Hospital Research 
Ethics Committee approved the present study, and all patients signed 
a general informed consent form following hospital admission. At this 
institution, professionals have constantly been trained to perform the 
UD- CUS technique since it was developed in 2010.
Four cases had a multiple pregnancy (9.8%) and 31 (75.6%) had 
some type of comorbidity, with hypertensive disorders being the most 
frequent (34.1%). The main PPH etiology was atony (82.9%). There was 
accretism in three patients and uterine rupture in two. Four patients 
presented placental abruption and one of them developed Couvelaire 
uterus. Placenta previa was diagnosed in one case. Only one patient had 
PPH after vaginal delivery. Hemorrhage began during cesarean delivery 
in 33 cases (80.5%) and after the procedure in seven cases (17.1%).
All patients underwent pharmacological therapy and prophylactic 
antibiotic treatment before undergoing UD- CUS. The first line of therapy 
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included volume resuscitation, uterotonic agents (oxytocins, prostaglan-
dins, and ergot alkaloids) and/or tranexamic acid. If the bleeding continued 
despite pharmacological therapy, the UD- CUS technique was considered.
The shock index (>0.9) revealed that 17 patients (41.5%) suffered 
hypovolemic shock at some point of the procedure. Six patients were 
treated with vasoactive amines and 18 patients received blood trans-
fusions. Blood loss was estimated by weighing surgical pads in only 
12 patients (29.3%) and varied between 480 and 3200 mL (mean of 
1685.7 ± 914.9 mL).
The UD- CUS technique provided hemorrhagic control in 38 
patients with a success rate of 92.7%. In the cases of three patients 
in whom hemostatic control was not achieved, diagnosis and abdom-
inal hysterectomy was required within hours or up to 3 days after the 
procedure. All patients survived, and six (14.6%) had surgical compli-
cations (three cases of abdominal wall hematoma, two of pelvic hema-
toma and one case of puerperal endometritis).
Fotopoulou et al. recommend caution in combining the CUS 
technique with vascular ligatures due to the risk of uterine ischemic 
necrosis.4 When performing the UD- CUS technique, the compressive 
vertical braces are tied from the uterus fundus to the lower segment, 
thus preventing the uterine walls from collapsing and preventing inter-
ference in blood drainage. In this series, none of the patients devel-
oped an ischemic phenomenon in the short- term.
The success rate achieved using the UD- CUS technique in this study 
was comparable to previous studies. Chai et al. observed an increase in 
success rates of CUS from 66% to 74% when the procedure was per-
formed in combination with devascularization techniques.5 Similarly, 
Kaya et al. described an improvement from 75% to 94.4% when devas-
cularization techniques were combined with B- Lynch suture.6
The UD- CUS technique controlled bleeding in all three cases of 
accretism. This achievement could be attributed to mild accretism and 
blood irrigation from the S1 genital vascular territory. The UD- CUS 
technique is preferable in hemorrhages coming from this territory 
because vascular ligature is performed in the ascending branches of 
the uterine arteries.
Compared to the WHO Guideline recommendations, this tech-
nique is suitable for treatment of PPH, surgical maneuvers and other 
procedures (strong recommendation, very low- quality evidence).7
The present study does have some limitations, such as the lack of 
a control group and the fact that the sample was obtained by conve-
nience. The strengths of the present study include the fact that the 
UD- CUS technique only requires four needle passages through the 
uterus, which facilitates execution, and that the success rate is compa-
rable to that reported in previous literature.
In conclusion, this strategy integrates a set of surgical tech-
niques that preserve the uterus, mainly in hemorrhages during 
cesarean delivery and in bleeding associated with S1 genital 
vascular territory.
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F IGURE  1 Schematic representation of uterine devascularization 
and compressive uterine suture (UD- CUS) technique according to the 
genital vascular territories.
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